Trevor J. McGill

Dr. Trevor J. McGill is a Research Assistant Professor at the Casey Eye Institute, Oregon Health & Science University (OHSU), School of Medicine. His research focuses on developing cell-based and gene therapies for retinal degenerative diseases using rodent and nonhuman primate models.

His educational background includes:

• B.S. in 2002 from The University of Lethbridge
• MSc in 2004 from The University of Lethbridge
• Ph.D. in 2008 from The University of Lethbridge

Dr. McGill's primary research interests include Retinitis Pigmentosa and Age-related Macular Degeneration. His lab employs both rodent and nonhuman primate models to translate cell-based and gene therapies into clinical trials for retinal degenerative diseases. His work spans gene therapy, stem cell therapy, and the development of preclinical models for diabetic retinopathy and other retinal conditions.

Analysis of Dr. McGill's recent publications (2019-2025) reveals a strong focus on translational ophthalmology, particularly in stem cell and gene therapy for retinal degeneration. Key trends include the use of nonhuman primate models, development of gene augmentation therapies (e.g., for CNGB1-retinitis pigmentosa), and investigation of diabetic retinopathy mechanisms. His work also extends to immunology in transplantation and mitochondrial genetics.

Dr. McGill leads a research laboratory at the Casey Eye Institute that utilizes advanced models of retinal degeneration. His team collaborates extensively with other researchers at OHSU and beyond, as evidenced by multi-institutional publications.